Roivant Sciences Ltd.ROIVNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-1.02B
↓ 13% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-897.19M
Historical baseline
PeriodValueYoY Change
TTM$-1.02B+7.7%
2024$-1.10B-37.0%
2023$-802.89M+31.8%
2022$-1.18B-29.3%
2021$-910.77M-26.4%
2020$-720.58M-30.2%
2019$-553.30M-